EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial Activity of Pediococcus pentosaceus PMY2 Against Multidrug-Resistant Pathogens

Gyeong-Seon Yi iD, Xiangji Jin iD, Qiwen Zheng iD, Trang Thi Minh Nguyen iD, Su-Jin Yang iD, Tae-Hoo Yi iD

Antibiotics · 08.04.2025 · 14 (4) · 389

DOI: 10.3390/antibiotics14040389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 08.04.2025. Verfasst von Gyeong-Seon Yi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Convergent Biotechnology and Advanced Materials Engineering, Graduate School, Kyung Hee University, Yongin 17104, Republic of Korea. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Multidrug-resistant (MDR) pathogens pose a critical challenge in infection treatment. Pediococcus pentosaceus (P. pentosaceus) is known for its antimicrobial activity; however, studies on its effects against MDR pathogens remain limited. This study aimed to evaluate the antimicrobial and biological activities of P. pentosaceus PMY2, isolated from fermented porcine colostrum yogurt, against MDR pathogens, including Staphylococcus aureus (S. aureus), Pseudomonas aeruginosa (P. aeruginosa), and Escherichia coli (E. coli).

Methods

The antimicrobial, anti-inflammatory, and cytotoxic effects of P. pentosaceus PMY2 were evaluated in vitro. In addition, IL-6 and TNF-α levels were analyzed using an ELISA kit.

Results

The MIC value against S. aureus KCTC 3881 and MRSA (CCARM 3089) was 0.31 mg/mL, while the MBC values were 0.63 mg/mL and 2.5 mg/mL, respectively. At MIC, biofilm formation was inhibited by 62.2% in S. aureus KCTC 3881 and by 51.5% in MRSA. CFS exhibited low cytotoxicity in RAW 264.7 macrophages and significantly reduced NO production, IL-6, and TNF-α levels, indicating strong anti-inflammatory effects.

Conclusions

These findings suggest that P. pentosaceus PMY2 exhibited excellent antimicrobial and anti-inflammatory activity against MDR pathogens, demonstrating its potential as a natural antimicrobial agent. These results indicate that PMY2 CFS could be a promising candidate for addressing antibiotic resistance issues.

Schlagwörter

Stichwörter der Autor:innen

MDRPediococcus pentosaceusanti-inflammatory effectantimicrobial activitylactic acid bacteriamultidrug-resistant pathogens

Autor:innen und Institutionen

  • Department of Convergent Biotechnology and Advanced Materials Engineering, Graduate School, Kyung Hee University, Yongin 17104, Republic of Korea.
  • Department of Dermatology, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
  • Graduate School of Biotechnology, Kyung Hee University, Yongin 17104, Republic of Korea.

ORCID-Profile: Gyeong-Seon Yi, Xiangji Jin, Qiwen Zheng, Trang Thi Minh Nguyen, Su-Jin Yang, Tae-Hoo Yi

Zitieren

APA

Yi, G. S., Jin, X., Zheng, Q., Nguyen, T. T. M., Yang, S. J., & Yi, T. H. (2025). Antimicrobial Activity of Pediococcus pentosaceus PMY2 Against Multidrug-Resistant Pathogens. Antibiotics, 14(4), 389. https://doi.org/10.3390/antibiotics14040389

Vancouver

Yi GS, Jin X, Zheng Q, Nguyen TTM, Yang SJ, Yi TH. Antimicrobial Activity of Pediococcus pentosaceus PMY2 Against Multidrug-Resistant Pathogens. Antibiotics. 2025;14(4):389. doi:10.3390/antibiotics14040389

BibTeX
@article{Yi2025,
  author = {Yi, Gyeong-Seon and Jin, Xiangji and Zheng, Qiwen and Nguyen, Trang Thi Minh and Yang, Su-Jin and Yi, Tae-Hoo},
  title = {Antimicrobial Activity of Pediococcus pentosaceus PMY2 Against Multidrug-Resistant Pathogens},
  journal = {Antibiotics},
  year = {2025},
  volume = {14},
  number = {4},
  pages = {389},
  doi = {10.3390/antibiotics14040389}
}
Kostenlos starten →